Harbor Advisors LLC Makes New $261,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Harbor Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, Holdings Channel reports. The fund bought 500 shares of the medical equipment provider’s stock, valued at approximately $261,000.

Other institutional investors also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $31,000. Finally, Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $36,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on ISRG shares. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Robert W. Baird cut their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Finally, Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG opened at $492.49 on Friday. The firm has a 50 day moving average price of $562.24 and a 200 day moving average price of $531.67. The company has a market cap of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.